The company claims its semaglutide drops, which are applied under the tongue, contain the same active ingredient found in Ozempic and Wegovy and provide the powerful benefits of GLP-1 without injections. EllieMD further touts, under a benefits tab on the drops product page, that the drops offer prescription appetite suppression and are scientifically backed to help users lose weight, adding that the drops can help to lower blood sugar levels and potentially reduce the risk factors associated with conditions like type 2 diabetes, high blood pressure and cardiovascular disease, which are often linked to diabetes. Meanwhile, a recent EllieMD Instagram post boasts about the cardiovascular benefits of its GLP-1 medication, including decreased risk of cardiovascular disease, heart attack and stroke
Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B
this model is static PES improves separation but remains a single perturbation snapshot MEA captures correlates of state transitions, not full continuous dynamics This paper shows local cortical dynamics only (not whole-brain physiology) so results are: developmental-stage dependent model-specific (2D organoid in vivo brain) perturbation-dependent Why fully dynamic modeling is nearly impossible
GSH depletion also occurs in pulmonary diseases (chronic obstructive pulmonary disease, asthma, and acute respiratory distress syndrome) and immune diseases such as HIV and autoimmune diseases
Doses ranging from 1.5 to 3 grams per day for at least three months consistently show improvements in cognitive function several-fold greater than placebo, with significant improvements in attention, memory, and intellectual functioning
